Tavros Therapeutics

We are excited to announce that Tavros is now officially a part of Vividion Therapeutics, Inc.!?Together, our shared commitment to innovation and scientific excellence will help accelerate new solutions for patients.

It was a pleasure hosting the CED team at Tavros HQ! Thank you for continuing to support and empower biotech startups in RTP.

?? Last week, we celebrated 5 years of Tavros Therapeutics! ? Cheers to our talented, innovative, and collaborative employees who make Tavros such a dynamic place to work. We are proud of the passion and commitment our team brings every day as we continue to research and develop targeted cancer therapies. ???? Thank you to our investors and partners for their continued support and belief in our vision. #TeamTavros #cancer #precisiononcology #syntheticlethality

#TeamTavros participated in the Gail Parkins Ovarian Cancer Walk/5k event this past weekend. We successfully surpassed our fundraising goal and raised just under $2,000, which will all go directly towards ovarian cancer research at the Duke University GYN/Oncology Division! Thank you to our employees, family, friends, and colleagues who donated and showed their support at this wonderful event. It was an honor and privilege to raise awareness and give back to the #ovariancancer community. ????♀?????????

Tavros is a proud sponsor of the Gail Parkins Memorial Ovarian Cancer Walk & 5k Run this fall! Our team is excited to raise awareness about ovarian cancer, pay tribute to those touched by the disease, and provide financial support for ovarian cancer research efforts at Duke University Medical Center. We are honored to take part in such a noble cause and look forward to supporting the #ovariancancer community on September 21st. If you’re interested in joining Team Tavros, click the link to visit our team page. We hope to see you there! ??♂? https://lnkd.in/ditZ2Z2g

We are excited to announce that our CFO, Nikki Heron, has been selected as one of the winners for the Triangle Business Journal’s 2024 Corporate Leadership Awards! ???? These awards recognize outstanding C-level executives for their contributions to the Triangle community. Nikki’s hard work, dedication, and expertise play a pivotal role in Tavros’ success. We are lucky to have Nikki on #TeamTavros! https://lnkd.in/exQ-8iH3

????Exciting news!??? ? We're thrilled to announce that Tavros Therapeutics has been selected as one of the Triangle Business Journal's 2024 Best Places to Work Award winners!??? ? This incredible honor reflects our commitment to fostering an inclusive, innovative, and supportive work environment where every team member can thrive. A huge thank you to our dedicated employees for making Tavros a truly special place to work. Your passion, creativity, and teamwork are the driving forces behind our success and our mission to develop targeted #cancer therapies. ? #BestPlacestoWork #TeamTavros? ? https://lnkd.in/eW_v-CHG

Exciting news!????Tavros has achieved two milestone payments in our collaboration with Vividion Therapeutics. Together, we're pushing the boundaries of potential #cancertreatments by merging Vividion’s chemoproteomics approach with Tavros’ expertise in #syntheticlethality. This collaboration aims to unveil novel druggable vulnerabilities in tumor cells.?We are thrilled by our progress together so far! https://lnkd.in/eu-U_nii

Tavros Therapeutics?is excited?to attend the BIO 2024 Conference!??? ? As we gear up for #BIO2024, we’d?love to meet and discuss potential collaborations surrounding our work leveraging synthetic vulnerabilities in tumors to accelerate the discovery and development of first-in-class #precisionmedicines to advance #cancertreatments.? ? Tavros’?EVOLVE? platform?can precisely and directly identify the paired?#genetic?interactions that form the basis for breakthrough targeted oncology therapies, for our own pipeline or our partner’s. ? If you're interested in #syntheticlethality, targeted cancer therapies, or would like to hear about what we have in the works, we would love to connect with you during #BIO2024.?Click below to send Tavros Therapeutics a meeting request in the BIO partnering system! ? See you there!? ? https://lnkd.in/ehGW3SAd

A big thank you to John Strickler, MD,?for taking the time to speak with our staff about the innovative and life-changing work that’s taking place at the Duke Cancer Institute Molecular Tumor Board.?It was exciting to hear about their work using genomic profiling of patient tumors to optimize precision cancer medicine treatment strategies and improve clinical trial access. Seeing the real-world impact precision cancer therapy is having?on patients leaves us more inspired than ever to?continue our work in developing targeted #cancer therapies to?improve?patient outcomes.